Curated from NYT > Business — Here’s what matters right now:
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
Next step: Keep your day-to-day compliant and secure—find privacy-forward devices that help you stay protected.
Original reporting: NYT > Business